| scholarly article | Q13442814 |
| P50 | author | Kathleen T. Unroe | Q91794243 |
| P2093 | author name string | Wanzhu Tu | |
| Christopher M Callahan | |||
| Hugh C Hendrie | |||
| Timothy E Stump | |||
| Daniel O Clark | |||
| P2860 | cites work | Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline | Q22241139 |
| Economic considerations in the management of Alzheimer's disease | Q22241448 | ||
| Cholinesterase inhibitors for Alzheimer's disease | Q22252975 | ||
| The Indiana network for patient care: a working local health information infrastructure. An example of a working infrastructure collaboration that links data from five health systems and hundreds of millions of entries | Q28272207 | ||
| Monetary costs of dementia in the United States | Q28288245 | ||
| Cost-effectiveness of drug therapies for Alzheimer's disease: A brief review | Q30441091 | ||
| Agreement between self-reported and routinely collected health-care utilization data among seniors | Q30705604 | ||
| Clinical features associated with costs in early AD: baseline data from the Predictors Study. | Q31036417 | ||
| A Systematic Review to Assess the Policy-Making Relevance of Dementia Cost-of-Illness Studies in the US and Canada | Q33751490 | ||
| Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. | Q33979412 | ||
| Self-reports of health care utilization compared to provider records | Q34134630 | ||
| The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model | Q34249879 | ||
| A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study | Q34433704 | ||
| ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderly | Q35588243 | ||
| Clinical characteristics and longitudinal changes of informal cost of Alzheimer's disease in the community | Q35588248 | ||
| Cost effectiveness of cholinesterase inhibitors in the treatment of Alzheimer's disease: a review with methodological considerations | Q35709836 | ||
| Transitions in care for older adults with and without dementia | Q35967441 | ||
| Self-reported utilization of health care services: improving measurement and accuracy | Q36440777 | ||
| Effectiveness of nonpharmacological interventions in delaying the institutionalization of patients with dementia: a meta-analysis | Q37137904 | ||
| DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT | Q37295359 | ||
| Early identification and treatment of Alzheimer's disease: social and fiscal outcomes | Q37449105 | ||
| Cost-of-illness studies of dementia: a systematic review focusing on stage dependency of costs. | Q37582963 | ||
| Systematic review of economic evaluations of Alzheimer's disease medications | Q37763138 | ||
| A review of the methods used to estimate the cost of Alzheimer's disease in the United States | Q37874387 | ||
| The clinical significance of cognition-focused interventions for cognitively impaired older adults: a systematic review of randomized controlled trials | Q37899286 | ||
| Application of Resource Utilization in Dementia (RUD) instrument in a global setting | Q38059037 | ||
| Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial | Q38407145 | ||
| Accuracy of self-reported health services use and patterns of care among urban older adults | Q38467814 | ||
| Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease | Q42602615 | ||
| Economic evaluation of donepezil in moderate to severe Alzheimer disease | Q45028141 | ||
| ADCS Prevention Instrument Project: overview and initial results. | Q50793413 | ||
| Net costs of dementia by disease stage. | Q51168441 | ||
| Helping caregivers of persons with dementia: which interventions work and how large are their effects? | Q52018206 | ||
| Comparison of self-reported and medical record health care utilization measures. | Q52888995 | ||
| Assessing outcomes in Alzheimer disease. | Q53244761 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 75-81 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Alzheimer Disease and Associated Disorders | Q4738827 |
| P1476 | title | Errors in self-reports of health services use: impact on alzheimer disease clinical trial designs | |
| P478 | volume | 29 |
| Q38852096 | Accuracy of Caregiver Proxy Reports of Home Care Service Use. |
| Q43170003 | Consider the Source: The Implications of Informant Type on Outcome Assessments |
| Q37260376 | Diagnosis, misdiagnosis, lucky guess, hearsay, and more: an ontological analysis |
| Q47672288 | Secondary Analysis of Existing Datasets for Dementia and Palliative Care Research: High-Value Applications and Key Considerations. |
| Q46028917 | Study partners should be required in preclinical Alzheimer's disease trials. |
Search more.